Search by Drug Name or NDC
NDC 70710-1161-03 Meclizine Hydrochloride 12.5 mg/1 Details
Meclizine Hydrochloride 12.5 mg/1
Meclizine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals (USA) Inc.. The primary component is MECLIZINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
Related Packages: 70710-1161-03Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Meclizine
Product Information
| NDC | 70710-1161 |
|---|---|
| Product ID | 70710-1161_70fc6598-0591-4201-83d4-01fa12f806e3 |
| Associated GPIs | 50200050000305 |
| GCN Sequence Number | 004731 |
| GCN Sequence Number Description | meclizine HCl TABLET 12.5 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 18301 |
| HICL Sequence Number | 001975 |
| HICL Sequence Number Description | MECLIZINE HCL |
| Brand/Generic | Generic |
| Proprietary Name | Meclizine Hydrochloride |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Meclizine Hydrochloride |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 12.5 |
| Active Ingredient Units | mg/1 |
| Substance Name | MECLIZINE HYDROCHLORIDE |
| Labeler Name | Zydus Pharmaceuticals (USA) Inc. |
| Pharmaceutical Class | Antiemetic [EPC], Emesis Suppression [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA213957 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 70710-1161-03 (70710116103)
| NDC Package Code | 70710-1161-3 |
|---|---|
| Billing NDC | 70710116103 |
| Package | 30 TABLET in 1 BOTTLE (70710-1161-3) |
| Marketing Start Date | 2020-10-29 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |